AAV2/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra as early stage model of Parkinson’s disease

被引:0
|
作者
Friederike Freiin von Hövel
Regina Rumpel
Andreas Ratzka
Dietmar Schreiner
Claudia Grothe
机构
[1] Hannover Medical School,Institute of Neuroanatomy and Cell Biology
[2] Hannover Medical School,Center for Systems Neuroscience (ZSN)
[3] Institute of Neuroanatomy and Cell Biology,Institute for Laboratory Animal Science and Central Animal Facility
[4] Hannover Medical School,undefined
来源
Cell and Tissue Research | 2019年 / 378卷
关键词
Parkinson’s disease; AAV2/DJ; Alpha-synuclein; Rat model; E46K;
D O I
暂无
中图分类号
学科分类号
摘要
Parkinson’s disease (PD) is pathologically characterized by the progressive loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) and alpha-synucleinopathy. We mimic the disease pathology with overexpression of either the human α-syn wildtype (α-syn-WT) or E46K mutant form (α-syn-E46K) in DA neurons of the SNpc in adult rats using AAV2/DJ as a viral vector for the first time. Transduction efficiency was compared to an equal virus titer expressing the green fluorescent protein (GFP). Motor skills of all animals were evaluated in the cylinder and amphetamine-induced rotation test over a total time period of 12 weeks. Additionally, stereological quantification of DA cells and striatal fiber density measurements were performed every 4 weeks after injection. Rats overexpressing α-syn-WT showed a progressive loss of DA neurons with 40% reduction after 12 weeks accompanied by a greater loss of striatal DA fibers. In contrast, α-syn-E46K led to this reduction after 4 weeks without further progress. Insoluble α-syn positive cytoplasmic inclusions were observed in both groups within DA neurons of the SNpc and VTA. In addition, both α-syn groups developed a characteristic worsening of the rotational behavior over time. However, only the α-syn-WT group reached statistically significant different values in the cylinder test. Summarizing these effects, we established a motor symptom animal model of PD by using AAV2/DJ in the brain for the first time. Thereby, overexpressing of α-syn-E46K mimicked a rather pre-symptomatic stage of the disease, while the α-syn-WT overexpressing animals imitated an early symptomatic stage of PD.
引用
收藏
页码:1 / 14
页数:13
相关论文
共 50 条
  • [1] AAV2/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra as early stage model of Parkinson's disease
    von Hoevel, Friederike Freiin
    Rumpel, Regina
    Ratzka, Andreas
    Schreiner, Dietmar
    Grothe, Claudia
    CELL AND TISSUE RESEARCH, 2019, 378 (01) : 1 - 14
  • [2] Rapamycin attenuates nigral and hippocampal alpha-synuclein accumulation in AAV-mediated alpha-synuclein overexpression model of Parkinson's disease
    Cinar, E.
    Yalcin-Cakmakli, G.
    Ulusoy, A.
    Saka, E.
    Tel, B.
    Elibol, B.
    MOVEMENT DISORDERS, 2021, 36 : S332 - S332
  • [3] A promising model for cognitive dysfunction in Parkinson's Disease by AAV-mediated alpha-synuclein overexpression in hippocampus
    Cinar, E.
    Yalcin-Cakmakli, G.
    Saka, E.
    Ulusoy, A.
    Tel, B.
    Elibol, B.
    MOVEMENT DISORDERS, 2018, 33 : S586 - S586
  • [4] Morphological and Behavioral Impact of AAV2/5-Mediated Overexpression of Human Wildtype Alpha-Synuclein in the Rat Nigrostriatal System
    Gombash, Sara E.
    Manfredsson, Fredric P.
    Kemp, Christopher J.
    Kuhn, Nathan C.
    Fleming, Sheila M.
    Egan, Ann E.
    Grant, Laura M.
    Ciucci, Michelle R.
    MacKeigan, Jeffrey P.
    Sortwell, Caryl E.
    PLOS ONE, 2013, 8 (11):
  • [5] Modelling Non-motor Symptoms of Parkinson's Disease: AAV Mediated Overexpression of Alpha-synuclein in Rat Hippocampus and Basal Ganglia
    Mutluay, Sevgi Ugur
    Cinar, Elif
    Cakmakli, Gul Yalcin
    Ulusoy, Ayse
    Elibol, Bulent
    Tel, Banu Cahide
    TURKISH JOURNAL OF NEUROLOGY, 2020, 26 (04) : 322 - 329
  • [6] Gait analysis in the Gottingen minipig model of Parkinson disease based on alpha synuclein overexpression in the substantia nigra
    Mogensen, P.
    Glud, A. N.
    Hedegaard, C.
    Nielsen, M. S.
    Larsen, K.
    Jensen, P. H.
    Bendixen, C.
    Sorensen, J. C.
    Bjarkam, C. R.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S92 - S92
  • [7] Therapeutic Effects of Selenium on Alpha-Synuclein Accumulation in Substantia Nigra Pars Compacta in a Rat Model of Parkinson’s Disease: Behavioral and Biochemical Outcomes
    Sanaz Salaramoli
    Hamid Reza Joshaghani
    Mahmoud Hosseini
    Seyed Isaac Hashemy
    Biological Trace Element Research, 2024, 202 : 1115 - 1125
  • [8] Therapeutic Effects of Selenium on Alpha-Synuclein Accumulation in Substantia Nigra Pars Compacta in a Rat Model of Parkinson's Disease: Behavioral and Biochemical Outcomes
    Salaramoli, Sanaz
    Joshaghani, Hamid Reza
    Hosseini, Mahmoud
    Hashemy, Seyed Isaac
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2024, 202 (03) : 1115 - 1125
  • [9] In vivo alpha-synuclein overexpression in rodents: A useful model of Parkinson's disease?
    Chesselet, Marie-Francoise
    EXPERIMENTAL NEUROLOGY, 2008, 209 (01) : 22 - 27
  • [10] Role of complement in an alpha-synuclein overexpression model of Parkinson disease
    Allen, Heather E.
    Thomas, Caitlin B.
    Harms, Ashley S.
    Standaert, David G.
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 86 - 86